File contents:
A. Cancer sites, stages, age groups
B. Survival estimates codebook
C. Citation

*** A. Cancer sites ***
11 cancer sites were included in the model

|Index|Site                  |ICD-O-3 Topography Code|
|-----|----------------------|-----------------------|
|0    |Oesophagus            |C15                    |
|1    |Stomach               |C16                    |
|2    |Colon                 |C18                    |
|3    |Rectum                |C19-20                 |
|4    |Anus                  |C21                    |
|5    |Liver                 |C22                    |
|6    |Pancreas              |C25                    |
|7    |Lung                  |C33-34                 |
|8    |Breast (females)      |C50                    |
|9    |Cervix uteri (females)|C53                    |
|10   |Prostate (males)      |C61                    |

4 cancer stages were modeled (TNM I-IV)

|Index|Stage|
|-----|-----|
|0    |I    |
|1    |II   |
|2    |III  |
|3    |IV   |

5 age groups were modeled

|Index|Age Group  |
|-----|-----------|
|0    |0-19 years |
|1    |20-39 years|
|2    |40-54 years|
|3    |55-69 years|
|4    |70+ years  |


*** B. Survival estimates codebook ***
Estimated 5-year net survival for patients diagnosed in 2018

|File             |Contents                               |
|-----------------|---------------------------------------|
|Surv_Mean.csv    |Estimated survival indicators - mean   |
|Surv_LB.csv      |Estimated survival indicators - 95% LB |
|Surv_UB.csv      |Estimated survival indicators - 95% UB |

Column headers

|Column Label      |Column Index|Description                                             |
|------------------|------------|--------------------------------------------------------|
|name              |           0|Name of geographic area                                 |
|ISOCode           |           1|Country code  (ISO-3)                                   |
|deaths            |           2|Cancer deaths, all 11 cancers combined                  |
|surv_Overall      |           3|5-year net survival, all 11 cancers combined            |
|dxCases_0         |           4|Number of diagnosed cases, cancer 0 (Oesophagus)        |
|...               |...         |...                                                     |
|dxCases_10        |          14|Number of diagnosed cases, cancer 10 (Prostate)         |
|dx_0_stage_0      |          15|Stage I (%) at diagnosis, cancer 0 (Oesophagus)         |
|dx_1_stage_0      |          16|Stage I (%) at diagnosis, cancer 1 (Stomach)            |
|...               |...         |...                                                     |
|dx_10_stage_3     |          58|Stage IV (%) at diagnosis, cancer 10 (Prostate)         |
|dx_0_age_0        |          59|Age group 0 (%) at diagnosis, cancer 0 (Oesophagus)     |
|dx_1_age_0        |          60|Age group 0 (%) at diagnosis, cancer 1 (Stomach)        |
|...               |...         |...                                                     |
|dx_10_age_4       |         113|Age group 4 (%) at diagnosis, cancer 10 (Prostate)      |
|surv_dx_0         |         114|5-year net survival, cancer 0 (Oesophagus)              |
|...               |...         |...                                                     |
|surv_dx_10        |         124|5-year net survival, cancer 10 (Prostate)               |
|surv_dx_0_stage_0 |         125|5-year net survival, cancer 0 (Oesophagus), Stage I     |
|surv_dx_1_stage_0 |         126|5-year net survival, cancer 1 (Stomach), Stage I        |
|...               |...         |...                                                     |
|surv_dx_10_stage_3|         168|5-year net survival, cancer 10 (Prostate), Stage IV     |
|deaths_dx_0       |         169|Cancer deaths, cancer 0 (Oesophagus)                    |
|...               |...         |...                                                     |
|deaths_dx_10      |         179|Cancer deaths, cancer 10 (Prostate)                     |
|surv_stage_0      |         180|5-year net survival, Stage I, all 11 cancers combined   |
|...               |...         |...                                                     |
|surv_stage_3      |         183|5-year net survival, Stage IV, all 11 cancers combined  |
|stageDist_0       |         184|Stage I (%) at diagnosis, all 11 cancers combined       |
|...               |...         |...                                                     |
|stageDist_3       |         187|Stage IV (%) at diagnosis, all 11 cancers combined      |


*** C. Citation ***
Ward ZJ, Scott AM, Hricak H, Abdel-Wahab M, Paez D, Lette MM, Vargas HA, Kingham TP, Atun R.
Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
Lancet Oncol 2020; 21(8): 1077-1088.